Fetch is a mobile shopping platform that enables users to earn and redeem rewards.

Fetch is the leading mobile shopping platform that enables users to earn and redeem rewards. The platform provides users with the easiest way to save on everyday purchases by simply scanning their receipts. For their brand partners, the platform allows them to understand a 360-degree view of shopping habits, and to meaningfully reward a customer's individual loyalty.

Fetch

Senior Director

Senior Partner Director, Household Essentials

Adverum Biotechnologies is a gene therapy company that focuses on developing medicines that can offer therapeutic benefits to patients.

Adverum Biotechnologies is a clinical-stage company that aims to establish gene therapy as a new standard of care for a number of highly prevalent ocular diseases with the aspiration of developing functional cures for these diseases to restore vision and prevent blindness. Their services include gene therapy, biotechnology, rare diseases, ophthalmology, and retina.

Adverum Biotechnologies

Senior Director, CMC Lead

KBRA is a global rating agency established to restore trust in credit ratings and offer accurate and transparent ratings.

KBRA is a full service credit rating agency registered with the U.S. Securities and Exchange Commission as an NRSRO. In addition, KBRA is designated as a designated rating organization by the Ontario Securities Commission for issuers of asset-backed securities to file a short form prospectus or shelf prospectus, is recognized by the National Association of Insurance Commissioners as a Credit Rating Provider, and is a certified Credit Rating Agency (CRA) by the European Securities and Markets Authority (ESMA). Kroll Bond Rating Agency Europe Limited is registered with ESMA as a CRA.

Kroll Bond Rating Agency, Inc.

KBRA Financial Analytics - Senior Director

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

Pliant Therapeutics is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Pliant's lead product candidate, PLN-74809, is an oral small-molecule dual selective inhibitor of av√ü6 and av√ü1 integrins that it is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis, or PSC. PLN-74809 has received Orphan Drug Designation from the U.S. Food and Drug Administration for both IPF and PSC. Pliant is currently recruiting two Phase 2a trials of PLN-74809 for the treatment of IPF and plans to initiate a Phase 2a trial in PSC in the second half of 2020. Pliant's second product candidate, PLN-1474, is a small-molecule selective inhibitor of av√ü1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis, or NASH, which Pliant has partnered with Novartis. PLN-1474 is currently undergoing a Phase 1 trial. In addition to clinical stage programs, Pliant currently has two preclinical programs targeting oncology and muscular dystrophies.

Pliant Therapeutics

Senior Director, Global Program Team Leader

Symba is a project management and training company that offers management tools for talent development programs.

Symba is an internship management platform. Our easy-to-use enterprise SaaS tool helps companies streamline their internship program saving them time and money. Symba‚Äôs software enables employers to train interns, facilitate project workflows, measure performance, and build meaningful relationships. In this way, Symba provides oversight and transparency into internship programs and supports companies with real data to track their recruitment processes. Symba‚Äôs all-female founding team is diverse and brings together software, marketing, and business expertise. We are creating valuable experiences, one internship at a time.

Symba

Senior Director, Center for Racial Economic Equity

SpringWorks Therapeutics is a biopharmaceutical company focused on developing medicines for patients with severe rare diseases and cancer.

SpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for patients living with severe rare diseases and cancer. SpringWorks has a differentiated targeted oncology pipeline spanning solid tumors and hematological cancers, including two potentially registrational clinical trials in rare tumor types as well as several programs addressing highly prevalent, genetically defined cancers. SpringWorks‚Äô strategic approach and operational excellence in clinical development have enabled it to rapidly advance its two lead product candidates into late-stage clinical trials while simultaneously entering into multiple shared-value partnerships with innovators in industry and academia to unlock the full potential for its portfolio and create more solutions for patients with cancer.

SpringWorks Therapeutics

Senior Director Program Lead

SmartLabs builds and operates enterprise-grade labs, including multi-use R&D labs, vivariums, process development, and manufacturing suites.

SmartLabs designs, builds, and operates integrated, enterprise-grade research environments, including multifunctional research and development labs, vivariums, process development, pilot-scale manufacturing, and cGMP suites for companies of all sizes.

SmartLabs

Senior Director of Client Solutions

Recorded Future is the world's largest provider of intelligence for enterprise security.

Recorded Future is the world‚Äôs largest provider of intelligence for enterprise security. By combining persistent and pervasive automated data collection and analytics with human analysis, Recorded Future delivers intelligence that is timely, accurate, and actionable. In a world of ever-increasing chaos and uncertainty, Recorded Future empowers organizations with the visibility they need to identify and detect threats faster; take proactive action to disrupt adversaries; and protect their people, systems, and assets, so business can be conducted with confidence. Recorded Future is trusted by more than 1,000 businesses and government organizations around the world.

Location

Company Stage

Age of Data

Experience

Industry

Company

Senior Director

Fetch

$306k - $350k

$306,250 - $350,000

Adverum Biotechnologies

$263k - $280k

$263,000 - $280,000

Kroll Bond Rating Agency, Inc.

$150k - $210k

$150,000 - $210,000

Pliant Therapeutics

$75k

$74,809

Symba

N/A

N/A

SpringWorks Therapeutics

N/A

N/A

SmartLabs

N/A

N/A

Recorded Future

N/A

N/A